Sugi Predict

Sugi Predict / Targets / LRRC47

LRRC47

Leucine-rich repeat-containing protein 47 · Q8N1G4 · LRRC47 on Sugi Atlas →

0 patent compounds predicted against LRRC47, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to LRRC47 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Safety and Efficacy of Tag-7 Gene-modified Vaccine in Locally Advanced or Metastatic Malignant Melanoma or Kidney Cancer PHASE1/PHASE2COMPLETED
Effects of Lithium Therapy on Blood-based Therapeutic Targets in Parkinson's Disease. PHASE1COMPLETED
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases nanUNKNOWN
Genetic Characterization of Parkinson's Disease nanCOMPLETED
Molecular Genetic Epidemiology of Endocardial Cushion Defects - SCOR in Pediatric Cardiovascular Disease nanCOMPLETED
New Biomarkers for Diagnosis and Follow-up of Patients With LRBA or CTLA4 Deficiencies nanUNKNOWN
New Genes Involved in Molecular Etiology of Rett Syndrome Through DNA Microarray Comparative Genomic Hybridization nanCOMPLETED
Genetics of Rolandic Epilepsy nanCOMPLETED
Role of Sorcin and Annexin A3 in Breast Cancer Patients nanUNKNOWN
Epidemiological and Genetic Studies of Body Mass Index nanCOMPLETED
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH) nanCOMPLETED
Genetic Basis of Abdominal Aortic Aneurysm nanCOMPLETED
Genetic Variation in TRAF3IP2 (rs13190932) nanRECRUITING
Defining an Obesity QTL on Chromosome 3q nanCOMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Genetics of Familial and Sporadic ALS nanCOMPLETED
Nucleotide Protein -3 in Epileptic Children nanUNKNOWN
Changes in Skin Innervation of Neurologically Asymptomatic Type 2 Diabetic Patients: the Correlation With the Diabetic Parameters and Neurotrophins. nanUNKNOWN
Consortium On Risk for Early-onset Parkinson's Disease (CORE PD) nanCOMPLETED
Genetic Predictors of Lithium Response in Bipolar Disorder nanCOMPLETED
Autophagy Bladder Cancer nanUNKNOWN
Genetic Biomarkers for the Response to Anti-VEGF (Vascular Endothelial Growth Factor).Treatment in Wet Age-related Macular Degeneration (Wet ARMD) nanCOMPLETED
Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA nanRECRUITING
LobularCard Trial: Searching for Novel Germline Mutations in Lobular Breast Cancer Patients nanACTIVE_NOT_RECRUITING
Amyotrophic Lateral Sclerosis (ALS) Families Project nanRECRUITING
Assessing the Polygenic Burden of Rare Disruptive Mutations in Parkinson's Disease nanUNKNOWN
Rostock International Parkinson's Disease Study (ROPAD) nanCOMPLETED
Chromosome 5Q Gene Variants and Asthma-Related Traits nanCOMPLETED
Explore the Role of NLRP7 in the Regulation of Progestereone Induced Decidualization of Human Endometrial Stroma Cells nanCOMPLETED
The LD Lync Study - Natural History Study of Lipodystrophy Syndromes nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a LRRC47 binder may also engage these)

ProteinNameSimilarity
Q505F5 — 1.000 Q505F5 →
Q9Y613 — 0.976 Q9Y613 →
Q6P9Q4 — 0.972 Q6P9Q4 →
Q3UFQ8 — 0.972 Q3UFQ8 →
Q9WV70 — 0.971 Q9WV70 →
P17105 — 0.971 P17105 →
Q9BYB0 — 0.971 Q9BYB0 →
P47823 — 0.971 P47823 →
Q8TE68 — 0.971 Q8TE68 →
P70218 — 0.971 P70218 →
Q5XHY1 — 0.971 Q5XHY1 →
Q6NSJ5 — 0.971 Q6NSJ5 →
Q8ND23 — 0.970 Q8ND23 →
Q32P44 — 0.970 Q32P44 →
Q5NVK5 — 0.970 Q5NVK5 →
Q6F5E8 — 0.970 Q6F5E8 →
Q924T7 — 0.970 Q924T7 →
A7E3S5 — 0.970 A7E3S5 →
EIF2B5 Translation initiation factor eIF2B subunit epsilon 0.969 landscape →
MUS81 Structure-specific endonuclease subunit MUS81 0.969 landscape →
A0A8P0N4K0 — 0.969 A0A8P0N4K0 →
RNF31 E3 ubiquitin-protein ligase RNF31 0.968 landscape →
Q7T0L4 — 0.968 Q7T0L4 →
Q9NRL3 — 0.968 Q9NRL3 →
TELO2 Telomere length regulation protein TEL2 homolog 0.968 landscape →
Q8R5F8 — 0.968 Q8R5F8 →
O15211 — 0.968 O15211 →
A5A779 — 0.968 A5A779 →
O94810 — 0.968 O94810 →
Q3SYU1 — 0.968 Q3SYU1 →